| http://www.w3.org/ns/prov#value | - Thus, preferred combinations are simultaneous or alternating treatments of an ??????3 receptor antagonist of the present invention and a growth hormone secretagogue, optionally including a third component comprising an organic bisphosphonate, preferably alendronate monosodium trihydrate.
|
